Changes

Jump to: navigation, search

Fluvoxamine-vortioxetine

978 bytes removed, 18:19, 24 February 2023
no edit summary
| from = fluvoxamine
| to = vortioxetine
| stop = * '''Before day 1:''' gradually reduce dosage of fluvoxamine to a maximum of 50 mg/day, when this dosage is > 50 mg/day. * '''Day 1:''' when a dosage of 50 mg/day is reached{{StopSSRI, stop administrationSNRI}}| start = * A wash-out period is not necessary, but care is needed.* '''Day 1:''' start administration of vortioxetine in a dosage of 10 mg/day.{{StartAntidepressant}}
| info =
* Fluvoxamine is a strong inhibitor of CYP2C9, which metabolizes Safe target dose vortioxetine. * Occurrence of serotonin syndrome is theoretically possible, so caution is necessary.= 10 mg* Patients could be directly switched from a SSRI or a SNRI to vortioxetine 10 mg/day. One week after initiation with vortioxetine, the dosage could be increased from 10 mg/day to 20 mg/day.<ref>[http://www.ncbi.nlm.nih.gov/pubmed/25087600 Montgomery SA et al. A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelatine. Hum Psychopharmacol. 2014 Sep;29(5):470-82.]</ref>{{theorSS}}
}}

Navigation menu